- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 469–480 of 624
Second-Generation Antidepressants for Treating Adult Depression—An Update
Outline of Material
Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development
Rating the Strength of Evidence From the Comparative Effectiveness Review
Comparative Effectiveness Review on Second-Generation Antidepressants for Adults With Depression
Overall Comparative Effectiveness of Second-Generation Antidepressants for Treating Major Depressive Disorder
Overall Comparative Effectiveness of Second-Generation Antidepressants for Treating Adults With MDD
Keywords: efficacy | effectiveness | onset of action | elderly | adverse events
Comparative Effectiveness of Second-Generation Antidepressants in Continuation and Maintenance Phases
Comparative Effectiveness of Second-Generation Antidepressants in the Continuation and Maintenance Phases
Gaps in Knowledge (1 of 2)
Keywords: gaps in knowledge | efficacy | subgroups | comorbidities | duration | remission | dosage
Gaps in Knowledge (2 of 2)
Keywords: gaps in knowledge | effectiveness | combination therapy | anxiety | insomnia | pain | fatigue | serious adverse effects | suicidality
Selection of Data Sources for Observational Comparative Effectiveness Research
Your slide tray is being processed.